Contents - Pharma Technology Focus | Issue 143

Go to article: Home | Lula’s progress plan for Brazil: A year on

Go to article: Editor's letter

Go to article: Contents

Go to article: Mimotopes Company Insight

Go to article: Mimotopes

Go to article: Xylem

Go to article: Briefing

Go to article: News in Numbers

Go to article: Latest News

Go to article: Latest Deals

Go to article: Project Updates

Go to article: Trends & Insight

Go to article: phasetwo

Go to article: Datwyler Company Insight

Go to article: Datwyler

Go to article: In Depth

Go to article: Lula’s progress plan for Brazil: A year on

Go to article: How sham patents are hurting the pharma industry

Go to article: Tracking the opioid lawsuit settlements amidst calls for oversight

Go to article: Cell and gene therapy landscape in the US

Go to article: Q&A: Cell and gene therapy value assessments need a rework to allow access

Go to article: Pharmaceutical discovery through a gravitational lens

Go to article: Thematic Take: ESG

Go to article: Thematic Take: contents

Go to article: Foreword: A growing sense of urgency in ESG

Go to article: ESG 1.0 is over – get ready for ESG 2.0

Go to article: ESG becomes mandatory: how to prepare

Go to article: Theme timeline: the past, present and future of ESG

Go to article: Net-zero strategies for the pharma sector

Go to article: Leading pharma companies and initiatives in the race for net zero

Go to article: GlobalData’s Christopher Papadopoullos on net-zero strategy for businesses

Go to article: 38% of companies lack an ESG strategy – GlobalData survey

Go to article: Sustainability challenges in rare disease trials remain, but change is happening

Go to article: ESCMID 2024: The infectious consequences of climate change

Go to article: Bring your own device: How patients own tech is being used in clinical trials

Go to article: Can pharma overcome generative AI’s bias problem?

Go to article: China-US tensions are spilling into the biotech sector

Go to article: Japanese patients among least empowered in the developed world

Go to article: World Air Quality Report: what are the health impacts and where is it worst?

Go to article: Why has New Zealand U-turned on the world’s first smoking ban?

Go to article: Microplastics in placentas: how serious is the problem?

Go to article: Deal activity related to ESG in the pharma industry since 2021

Go to article: GlobalData Thematic Intelligence

Go to article: Sponsored Supplements

Go to article: BEA Technologies

Go to article: Cytiva

Go to article: Listings

Go to article: Events

Go to article: Innovation Rankings

Go to article: Buyer's Guides

Go to article: Next issue